{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-045605","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.590375+00:00","generated_at":"2026-05-25T13:37:31.800488+00:00","sec_items":["1.01","5.07","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Aadi Bioscience closes $100M PIPE; stockholders approve divestiture of FYARRO business","bullets":["Gross proceeds of $100M from PIPE led by Ally Bridge Group; 21.6M shares at $2.40 and 20.1M pre-funded warrants at $2.3999.","Stockholders approved sale of FYARRO business to KAKEN INVESTMENTS INC. (16.6M for, 3.5M against).","Equity plan amended to increase shares from 2.0M to 8.3M; annual reserve increase to 5% of outstanding.","Proceeds from PIPE and FYARRO sale, plus existing cash, expected to fund operations into 2028.","PIPE use includes upfront payments to WuXi Biologics and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-045605","json":"https://secwatch.observer/filing/0001193125-25-045605.json","markdown":"https://secwatch.observer/filing/0001193125-25-045605.md","text":"https://secwatch.observer/filing/0001193125-25-045605.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312525045605/0001193125-25-045605-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312525045605/d892218d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T13:37:31.800488+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}